Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin .1. Effects on the fetus and the neonate

被引:38
作者
Gehrs, BC
Riddle, MM
Williams, WC
Smialowicz, RJ
机构
[1] US EPA, NATL HLTH & ENVIRONM EFFECTS RES LAB, EXPT TOXICOL DIV, RES TRIANGLE PK, NC 27711 USA
[2] UNIV N CAROLINA, CURRICULUM TOXICOL, CHAPEL HILL, NC 27599 USA
关键词
F344; rat; fetus; neonate; 2,3,7,8-tetrachlorodibenzo-p-diosin;
D O I
10.1016/S0300-483X(97)00098-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Perinatal exposure of rodents to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been shown to result in thymic atrophy and cell-mediated immune suppression at lower doses than are required to produce those effects following adult exposure. This study was designed to examine the effects that in utero TCDD exposure has on thymocyte development in the rat. Timed-bred pregnant F344 rats were given 0, 1.0, or 3.0 mu g TCDD/kg body weight by gavage on gestational day 14 (GD14). On GD19 or GD22/postnatal day one (PD1), the dams were euthanized, and the dams and their offspring were examined for organ weight and thymus phenotypic alterations. GD19 fetuses from the 3.0 mu g TCDD/kg maternal exposure group exhibited decreases in relative thymus weight and thymic cellularity. There were a decreased percentage of CD3(-)/CD4(+)CD8(+) thymocytes and an increased percentage of CD3(-)/CD4-CD8+ thymocytes in these fetuses, but there were no alterations in the CD3(+) subsets. No effects were seen in the GD19 fetuses from the 1.0 mu g TCDD/kg dosage group. In the TCDD-exposed GD22/PD1 offspring thymic atrophy was no longer present, but there was an increase in the relative liver weight. In addition, there were decreased percentages of CD3(-)/CD4(-)CD8(-), CD3(+)/CD4(-)CD8(-), and CD3(+)/CD4(+)CD8(+) thymocytes and an increased percentage of CD3(+)/CD4(-)CD8(+) thymocytes. The CD3(+)/CD4(-)CD8(-) and CD3(+)/CD4(-)CD8(+) cell populations were the most sensitive, with changes appearing at both 1.0 and 3.0 mu g TCDD/kg maternal exposures. The TCDD-exposed GD19 dams exhibited an increased relative liver weight, a decreased relative thymus weight, and alterations in thymic CD3(+) populations. Three days later the relative organ weights had recovered in the dams, but the phenotypic alterations were seen in CD3(-) as well as CD3(+) thymocyte subsets. These results indicate that the developing rat fetal thymus is susceptible to the effects of TCDD. In addition, pregnant rats and their offspring showed similar alterations in thymocytic phenotypes. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 29 条
[1]  
*BBN SOFTW PROD CO, 1988, RS 1 REL 4
[2]   EXPOSURE TO TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) ALTERS FETAL THYMOCYTE MATURATION [J].
BLAYLOCK, BL ;
HOLLADAY, SD ;
COMMENT, CE ;
HEINDEL, JJ ;
LUSTER, MI .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 112 (02) :207-213
[3]   TOWARDS AN INTEGRATED VIEW OF THYMOPOIESIS [J].
BOYD, RL ;
HUGO, P .
IMMUNOLOGY TODAY, 1991, 12 (02) :71-+
[4]   THE THYMIC MICROENVIRONMENT [J].
BOYD, RL ;
TUCEK, CL ;
GODFREY, DI ;
IZON, DJ ;
WILSON, TJ ;
DAVIDSON, NJ ;
BEAN, AGD ;
LADYMAN, HM ;
RITTER, MA ;
HUGO, P .
IMMUNOLOGY TODAY, 1993, 14 (09) :445-459
[5]   THE THYMUS IN PREGNANCY - THE INTERPLAY OF NEURAL, ENDOCRINE AND IMMUNE INFLUENCES [J].
CLARKE, AG ;
KENDALL, MD .
IMMUNOLOGY TODAY, 1994, 15 (11) :545-551
[6]   COMPARATIVE ABILITY OF VARIOUS PCBS, PCDFS, AND TCDD TO INDUCE CYTOCHROME-P450 1A1 AND 1A2 ACTIVITY FOLLOWING 4 WEEKS OF TREATMENT [J].
DEVITO, MJ ;
MAIER, WE ;
DILIBERTO, JJ ;
BIRNBAUM, LS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1993, 20 (01) :125-130
[7]   ALTERATIONS IN THE CORTICAL THYMIC EPITHELIUM OF RATS AFTER INVIVO EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) - AN (IMMUNO)HISTOLOGICAL STUDY [J].
DEWAAL, EJ ;
SCHUURMAN, HJ ;
LOEBER, JG ;
VANLOVEREN, H ;
VOS, JG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 115 (01) :80-88
[8]   IMPAIRMENT OF THYMUS-DEPENDENT IMMUNE FUNCTIONS BY EXPOSURE OF DEVELOPING IMMUNE SYSTEM TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) [J].
FAITH, RE ;
MOORE, JA .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1977, 3 (03) :451-464
[9]  
FINE JS, 1989, MOL PHARMACOL, V35, P18
[10]  
FINE JS, 1990, J PHARMACOL EXP THER, V255, P128